David Awotwe‐Otoo

Application of quality by design elements for the development and optimization of an analytical method for protamine sulfate

David Awotwe‐Otoo, Cyrus Agarabi, Patrick J. Faustino et al. · Journal of Pharmaceutical and Biomedical Analysis · 2012 · 135 citations

Environmental Chemistry, Chemical Engineering, Engineering +15

Quality by design: Impact of formulation variables and their interactions on quality attributes of a lyophilized monoclonal antibody

David Awotwe‐Otoo, Cyrus Agarabi, Geoffrey Wu et al. · International Journal of Pharmaceutics · 2012 · 89 citations

Translational Medicine, Formulation Variables, Engineering +13

Impact of controlled ice nucleation on process performance and quality attributes of a lyophilized monoclonal antibody

David Awotwe‐Otoo, Cyrus Agarabi, Erik K. Read et al. · International Journal of Pharmaceutics · 2013 · 66 citations

Lyophilized Monoclonal Antibody, Medicine, Natural Sciences +9

Evaluation of Anticancer Drug-Loaded Nanoparticle Characteristics by Nondestructive Methodologies

David Awotwe‐Otoo, Ahmed S. Zidan, Ziyaur Rahman et al. · AAPS PharmSciTech · 2012 · 43 citations · Full text

Nanoparticles, Nanomedicine, Engineering +4

Physicochemical Characterization of Complex Drug Substances: Evaluation of Structural Similarities and Differences of Protamine Sulfate from Various Sources

David Awotwe‐Otoo, Cyrus Agarabi, David A. Keire et al. · The AAPS Journal · 2012 · 26 citations · Full text

Complex Drug Substances, Chemical Measurement, Biochemistry +13